Physician profile
Michael Golding
NPI 1528269768
$3,567.55
in general payments reported to CMS, 2019-2025
11 companies · $467 in 2025
The $467 reported for 2025 was more than what 77% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $267 · 2021: $889 · 2022: $635 · 2023: $738 · 2024: $174 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080 · Gift: $268 · Entertainment: $30.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.29 |
| Gift | $268.16 |
| Entertainment | $30.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $1,640.18 | 2019-2023 | Nobelactive |
| Carestream Dental, LLC | $634.84 | 2019-2022 | |
| Straumann USA LLC | $411.44 | 2019-2025 | |
| Salvin Dental Specialties, INC. | $274.25 | 2021 | |
| Geistlich Pharma, North America, INC. | $233.47 | 2024-2025 | Geistlich Bio-Gide, Biomaterials |
| Biohorizons Implant Systems INC. | $90.21 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $85.89 | 2019-2023 | Exparel, Zilretta |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $78.64 | 2023-2024 | |
| Ace Surgical Supply Co., INC. | $55.68 | 2022 | |
| Dentsply Sirona INC | $32.54 | 2019 | |
| Keystone Dental INC. | $30.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Golding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.